Microarray analysis of autoimmune diseases by machine learning procedures

IEEE Transactions on Information Technology in Biomedicine

Volumn 13, Issue 3, 2009, Pages 341-350

  Armañanzas, Rubén ^a   Calvo, Borja ^a   Inza, Iñaki ^a   López Hoyos, Marcos ^b   Martiacute nez Taboada, Víctor ^b   Ucar, Eduardo ^c   Bernales, Irantzu ^a   Fullaondo, Asier ^a   Larrañaga, Pedro ^d   Zubiaga, Ana M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

Author keywords

Antiphospholipid syndrome; DNA microarrays; Gene profiling; Machine learning(systemic lupus erythematosus

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ANTIPHOSPHOLIPID SYNDROMES; AUTOIMMUNE DISEASE; BINDING MOTIF; COMMON FEATURES; DATA DISCRETIZATION; DNA MICROARRAYS; EXPRESSION DATA; FUNCTIONAL CHARACTERIZATION; GENE EXPRESSION PROFILING; GENE SELECTION; GENETIC ORIGIN; HEALTHY INDIVIDUALS; MACHINE LEARNING(SYSTEMIC LUPUS ERYTHEMATOSUS; MACHINE-LEARNING; MICROARRAY ANALYSIS; MULTIVARIATE CORRELATION; ON-MACHINES; REGULATED GENES; REGULATORY PATHWAY; STATISTICAL ALGORITHM; STATISTICAL TECHNIQUES; STATISTICAL VALIDATION; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVARIATE;

BIOCHIPS; DNA; GENE EXPRESSION; LAWS AND LEGISLATION; NUCLEIC ACIDS; ROBOT LEARNING;

BIOASSAY;

ANALYSIS OF VARIANCE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ARTIFICIAL INTELLIGENCE; BAYES THEOREM; BIOLOGICAL MODEL; CLUSTER ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METHODOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANALYSIS OF VARIANCE; ANTIPHOSPHOLIPID SYNDROME; ARTIFICIAL INTELLIGENCE; BAYES THEOREM; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67349148108     PISSN: 10897771     EISSN: None     Source Type: Journal    
DOI: 10.1109/TITB.2008.2011984     Document Type: Article

References (78)

1. D. J. Lockhart, H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Norton, and E. L. Brown, "Expression monitoring by hybridization to high-density oligonucleotide arrays," Nat. Biotechnol., vol. 14, pp. 1675-1680, 1996.
2. M. Schena, D. Shalon, R. W. Davis, and P. O. Brown, "Quantitative monitoring of gene expression patterns with a complementary DNA microarray," Science, vol. 270, pp. 467-470, 1995.
3. E. C. Baechler, F. M. Batliwalla, A. M. Reed, E. J. Peterson, P. M. Gaffney, K. L. Moser, P. K. Gregersen, and T. W. Behrens, "Gene expression profiling in human autoimmunity," Immunol. Rev., vol. 210, pp. 120-137, 2006.
4. D. Alarcón-Segovia, "Shared autoimmunity: The time has come," Curr. Rheumatol. Rep., vol. 6, pp. 171-174, 2004.
5. P. K. Gregersen and T. W. Behrens, "Genetics of autoimmune diseases-disorders of immune homeostasis," Nat. Rev. Genet., vol. 7, no. 12, pp. 917-928, 2006.
6. C. G. Fathman, L. Soares, S. M. Chan, and P. J. Utz, "An array of possibilities for the study of autoimmunity," Nature, vol. 435, no. 7042, pp. 605-611, 2005.
7. I. V. Yang, E. Chen, J. P. Hasseman, W. Liang, B. C. Frank, S. Wang, V. Sharov, A. I. Saeed, J. White, J. Li, N. H. Lee, T. J. Yeatman, and J. Quackenbush, "Within the fold: Assessing differential expression measures and reproducibility in microarray assays," Genome Biol., vol. 3, no. 11, pp. research0062.1-research-0062.12, 2002.
8. L. Li, L. G. Pedersen, T. A. Darden, and C. R. Weinberg, "Computational analysis of leukemia microarray expression data using the GA/KNN method," in Proc. Methods Microarray Data Anal.: Papers CAMDA '00 2001, pp. 81-95.
9. P. Larrañaga, B. Calvo, R. Santana, C. Bielza, J. Galdiano, I. Inza, J. A. Lozano, R. Armañanzas, G. Santafé, A. Pérez, and V. Robles, "Machine learning in bioinformatics," Brief. Bioinformatics vol. 7, no. 1, pp. 86-112, 2006.
10. C. Bombardier, D. D. Gladman, M. B. Urowitz, D. Caron, and C. H. Chang, "Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE," Arthritis Rheum., vol. 35, no. 6, pp. 630-640, 1992.
11. Affymetrix, "Manufacturing quality control and validation studies of genechip arrays," Affymetrix, Inc., Santa Clara, CA, Tech. Note 701309 Rev. 2, 2002.
12. R. Armañanzas, "Solving bioinformatics problems by means of Bayesian classifiers and feature selection," University of the Basque Country, Leioa Telefono, Spain, Tech. Rep. EHU-KZAA IK-2/06, 2006.
13. S. Monti, P. Tamayo, J. Mesirov, and T. Golub, "Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data," Mach. Learn., vol. 52, no. 1/-2, pp. 91-118, Jul. 2003.
14. S. Swift, A. Tucker, V. Vinciotti, N. Martin, C. Orengo, X. Liu, and P. Kellam, "Consensus clustering and functional interpretation of gene-expression data," Genome Biol., vol. 5, no. 11, pp. R94.1-R94.16, 2004.
15. R. Kerber, "Chimerge : Discretization for numeric attributes," in Proc. Nat. Conf. Artif. Intell., 1992, pp. 123-128.
16. J. Catlett, "On changing continuous attributes into ordered discrete attributes," in Proc. Eur. Working Session Learn., 1991, pp. 164-178.
17. U. M. Fayyad and K. B. Irani, "Multi-interval discretization of continuous-valued attributes for classification learning," in Proc. 13th Int. Joint Conf. Artif. Intell., 1993, pp. 1022-1027.
18. N. Friedman, M. Linial, I. Nachman, and D. Pe'er, "Using Bayesian networks to analyze expression data," J. Comput. Biol., vol. 7, pp. 601-620, 2000.
19. H. C. Causton, J. Quackenbush, and A. Brazma, Microarray Gene Expression Data Analysis: A Beginner's Guide. Malden MA: Blackwell, May 2003.
20. J. Rissanen, "Modeling by shortest data description," Automatica vol. 14, pp. 465-471, 1978.
21. M. A. Hall and L. A. Smith, "Feature subset selection: A correlation based filter approach," in Proc. 4th Int. Conf. Neural Inf. Process. Intell. Inf. Syst., 1997, pp. 855-858.
22. M. Ben-Bassat, "Use of distance measures, information measures and error bounds in feature evaluation," in Handbook of Statistics, P. R. Krishnaiah and L. N. Kanal, Eds.. vol. 2. Amsterdam, The Netherlands: North-Holland, 1982, pp. 773-791.
23. T. M. Cover and J. A. Thomas, Elements Of Information Theory. New York: Wiley Interscience, 1991.
24. D. J. Wallace and B. H. Hahn, Dubois' Lupus Erythematosus: Baltimore, MD: Williams & Wilkins, 2002.
25. M. L. Bertolaccini, M. A. Khamashta, and G. R. Hughes, "Diagnosis of antiphospholipid syndrome," Nat. Clin. Pract. Rheumatol., vol. 1, no. 1, pp. 40-46, 2005.
26. R. H. Scofield, "Genetic knock out of 60 kD Ro (or SSA), a common lupus autoantigen, induces lupus," Trends Immunol., vol. 25, no. 1, pp. 13, 2003.
27. M. Srivastava, A. Rencic, G. Diglio, H. Santana, P. Bonitz, R. Watson, E. Ha, G. Anhalt, T. Provost, and C. Nousari, "Drug-induced, Ro/ SSA-positive cutaneous lupus erythematosus," Arch. Dermatol., vol. 139, no. 1, pp. 45-49, 2003.
28. P. J. Maddison, D. A. Isenberg, N. J. Goulding, J. Leddy, and R. P. Skinner, "Anti La (SSB) identifies a distinctive subgroup of systemic lupus erythematosus," Br. J. Rheumatol., vol. 27, no. 1, pp. 27-31, 1988.
29. I. Wichmann, M. A. Montes-Cano, N. Respaldiza, A. Alvarez, K. Walter, E. Franco, J. Sanchez-Roman, and A. Nunez-Roldan, "Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies," Scand. J. Gastroenterol., vol. 38, no. 9, pp. 996-999, 2003.
30. J. A. Hardin and J. O. Thomas, "Antibodies to histones in systemic lupus erythematosus: Localization of prominent autoantigens on histones h1 and h2b," Proc. Nat. Acad. Sci. USA, vol. 80, no. 24, pp. 7410-7414, 1983.
31. P. Correa, J. Molina, L. Pinto, M. Arcos-Burgos, M. Herrera, and J. Anaya, "TAP1 and TAP2 polymorphisms analysis in Northwestern Colombian patients with systemic lupus erythematosus," Ann. Rheum. Dis., vol. 62, no. 4, pp. 363-365, 2003.
32. C. Hualupusng, L. Hang, C. Chen, J. Wu, and F. Tsai, "Polymorphisms of TAP1 transporter genes in Chinese patients with systemic lupus erythematosus in Taiwan," Rheumatol. Int., vol. 24, no. 3, pp. 130-132, 2004.
33. Elvira Consortium, "Elvira: An environment for probabilistic graphical models," presented at the Electron. Proc. 1st Eur. Workshop Probabilistic Graph. Models, J. A. Gámez and A. Salmerón, Eds., Cuenca, Spain, Nov. 2002.
34. I. Inza, P. Larrañaga, R. Blanco, and A. J. Cerrolaza, "Filter versus wrapper gene selection approaches in DNA microarray domains," Artif. Intell. Med., vol. 31, no. 2, pp. 91-103, Jun. 2004.
35. S. Dudoit, Y. H. Yang, M. J. Callow, and T. P. Speed, "Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments," Statist. Sin., vol. 12, pp. 111-139, 2002.
36. J. W. Lee, J. B. Lee, M. Park, and S. H. Song, "An extensive comparison of recent classification tools applied to microarrays data," Comput. Statist. Data Anal., vol. 48, pp. 869-885, 2005.
37. S. Michiels, S. Koscielny, and C. Hill, "Prediction of cancer outcome with microarrays: A multiple random validation strategy," Lancet, vol. 365, pp. 488-92, 2005.
38. D. G. Kleinbaum, Logistic Regression. Statistics in Health Sciences New York: Springer-Verlag, 1994.
39. S. L. Cessie and J. C. V. Houwelingen, "Ridge estimators in logistic regression," Appl. Statist., vol. 41, no. 1, pp. 191-201, 1992.
40. D. W. Aha, D. Kibler, and M. K. Albert, "Instance-based learning algorithms," Mach. Learn., vol. 6, pp. 37-66, Jan. 1991.
41. G. H. John and P. Langley, "Estimating continuous distributions in Bayesian classifiers," in Proc. 11th Conf. Uncertainty Artif. Intell. San Mateo, CA: Morgan Kaufmann, 1995, pp. 338-345.
42. T. Bayes, "Essay towards solving a problem in the doctrine of chances," Philos. Trans. Roy. Soc. London, vol. 53, pp. 370-418, 1764.
43. L. Breiman, "Random forests," Mach. Learn, vol. 45, no. 1, pp. 5-32, Oct. 2001.
44. M. Stone, "Cross-validatory choice and assessment of statistical predictions," J. Roy. Statist. Soc. B, vol. 36, no. 2, pp. 111-147, 1974.
45. U. M. Braga-Neto and E. R. Dougherty, "Is cross-validation valid for small-sample microarray classification?," Bioinformatics, vol. 20, no. 3, pp. 374-380, 2004.
46. A. Statnikov, C. F. Aliferis, I. Tsamardinos, D. Hardin, and S. Levy, "A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis," Bioinformatics, vol. 21, no. 5, pp. 631-643, 2005.
47. B. Efron, "Estimating the error rate of a prediction rule: Improvement on cross-validation," J. Amer. Statist. Assoc., vol. 78, pp. 316-331, 1983.
48. S. M. Weiss and C. A. Kulikowski, Computer Systems that Learn. San Mateo, CA: Morgan Kaufmann, 1991.
49. R. R. Bouckaert and E. Frank, "Evaluating the replicability of significance tests for comparing learning algorithms," in Proc. Pacific-Asia Conf. Knowl. Discovery Data Mining - PAKDD, Sydney, Australia, 2004, pp. 3-12.
50. I. H. Witten and E. Frank, Data Mining: Practical Machine Learning Tools and Techniques, 2nd ed. San Francisco, CA: Morgan Kaufmann, 2005.
51. C. Nadeau and Y. Bengio, "Inference for the generalization error," Mach. Learn., vol. 52, no. 3, pp. 239-281, Sep. 2003.
52. A. Deng, S. Chen, Q. Li, S. C. Lyu, C. Clayberger, and A. M. Krensky, "Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator," J. Immunol., vol. 174, pp. 5243-5248, 2005.
53. Z. G. Jin, A. O. Lungu, L. Xie, M. Wang, and C. W. B. C. Berk, "Cyclophilin A is a proinflammatory cytokine that activates endothelial cells," Arterioscler. Thromb. Vasc. Biol., vol. 24, no. 7, pp. 1186-1191, 2004.
54. K. Zander, M. Sherman, U. Tessmer, K. Bruns, V. Wray, A. T. Prechtel, E. Schubert, P. Henklein, J. Luban, J. Neidleman, W. C. Greene, and U. Schubert, "Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression," J. Biol. Chem., vol. 278, no. 44, pp. 43 202-43 213, 2003.
55. H. B. Mann and D. R. Whitney, "On a test of whether one of 2 random variables is stochastically larger than the other," Ann. Math. Statist., vol. 18, pp. 50-60, 1947.
56. F. Al Shahrour, P. Mínguez, J. Tárraga, D. Montaner, E. Alloza, J. M. Vaquerizas, L. Conde, C. Blaschke, J. Vera, and J. Dopazo, "BABE-LOMICS: A systems biology perspective in the functional annotation of genome-scale experiments," Nucleic Acids Res., vol. 34, pp. w472-w476, 2006.
57. M. Mandel, M. Gurevich, R. Pauzner, N. Kaminski, and A. Achiron, "Autoimmunity gene expression portrait: Specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erithematosus," Clin. Exp. Immunol., vol. 138, pp. 164-170, 2004.
58. G. R. Burmester and T. Haupl, "Strategies using functional genomics in rheumatic diseases," Autoimmun. Rev., vol. 3, no. 7/8, pp. 541-549, 2004.
59. C. Johansson, "Exploring the genetics of SLE with linkage and association Analysis" Ph.D. dissertation, Uppsala Univ., Uppsala, Sweden, 2004.
60. S. Koskenmies, "Mapping of susceptibility genes for systemic lupus erythematosus (SLE)," Ph.D. dissertation, Univ. Helsinki, Helsinki, Finland, Mar. 2004.
61. B. P. Tsao, "The genetics of human systemic lupus erythematosus," Trends Immunol., vol. 24, no. 11, pp. 595-602, Nov. 2003.
62. R. Shai, F. P. Q. Jr, L. Li, O. Kwon, J. Morrison, D. J. Wallace, C. M. Neuwelt, C. Brautbar, W. J. Gauderman, and C. O. Jacob, "Genomewide screen for systemic lupus erythematosus susceptibility genes in multiplex families," Hum. Mol. Genet., vol. 8, no. 4, pp. 639-644, 1999.
63. M. Aringer and J. S. Smolen, "Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: A rationale for therapeutic intervention," Lupus, vol. 13, no. 5, pp. 344-347, 2004.
64. T. Horiuchi, C. Morita, H. Tsukamoto, H. Mitoma, T. Sawabe, S. Harashima, Y. Kashiwagi, and S. Okamura, "Increased expression of membrane TNF-alpha on activated peripheral CD8+T cells in systemic lupus erythematosus," Int. J. Mol. Med., vol. 17, no. 5, pp. 875-879, 2006.
65. Y. H. Lee, J. B. Harley, and S. K. Nath, "Meta-analysis of TNF-alpha promoter - 308 A/G polymorphism and SLE susceptibility," Eur. J. Hum. Genet., vol. 14, no. 3, pp. 364-371, 2006.
66. J. A. Croker and R. P. Kimberly, "Genetics of susceptibility and severity in systemic lupus erythematosus," Curr. Opin. Rheumatol. vol. 17, no. 5, pp. 529-537, 2005.
67. S. J. Rozzo, J. D. Allard, D. Choubey, T. J. Vyse, S. Izui, G. Peltz, and B. L. Kotzin, "Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus," Immunity, vol. 15, pp. 435-443, 2001.
68. E. C. Baechler, F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, and T. W. Behrens, "Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus," Proc. Nat. Acad. Sci. USA, vol. 100, no. 5, pp. 2610-2615, 2003.
69. L. Bennett, A. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual, "Interferon and granulopoiesis signatures in systemic lupus erythematosus blood," J. Exp. Med., vol. 197, no. 6, pp. 711-723, 2003.
70. R. K. Patel and C. Mohan, "PI3K/AKT signaling and systemic autoimmunity," Immunol. Res., vol. 31, no. 1, pp. 47-55, 2005.
71. H. C. Hsu, Y. Wu, and J. D. Mountz, "Tumor necrosis factor ligand-receptor superfamily and arthritis," Curr. Dir. Autoimmun. vol. 9, pp. 37-54, 2006.
72. P. B. Deming and J. C. Rathmell, "Mitochondria, cell death, and b cell tolerance," Curr. Dir. Autoimmun., vol. 9, pp. 95-119, 2006.
73. S. W. Cole, W. Yan, Z. Galic, J. Arevalo, and J. A. Zack, "Expression-based monitoring of transcription factor activity: The TELiS database," Bioinformatics, vol. 21, no. 6, pp. 803-810, 2005.
74. G. K. Kanji, 100 Statistical Tests. London, U.K.: Sage, 2006.
75. C. A. Berkes and S. J. Tapscott, "MyoD and the transcriptional control of myogenesis," Semin. Cell Dev. Biol., vol. 16, no. 4/5, pp. 585-595, 2005.
76. J. R. Nevins, "The Rb/E2F pathway and cancer," Hum. Mol. Genet., vol. 10, no. 7, pp. 699-703, 2001.
77. M. Murga, O. Fernández-Capetillo, S. J. Field, B. Moreno, L. R. Borlado, Y. Fujiwara, D. Balomenos, A. Vicario, A. C. Carreta, S. H. Orkin, M. E. Greenberg, and A. M. Zubiaga, "Mutation of E2F2 in mice causes enhanced t lymphocyte proliferation, leading to the development of autoimmunity," Immunity, vol. 15, no. 6, pp. 959-970, 2001.
78. R. L. Somorjai, B. Dolenko, and R. Baumgartner, "Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: Curses, caveats, cautions," Bioinformatics, vol. 19, no. 12, pp. 1484-1491, 2003.